Upload File

208686orig1s000 - food and drug administration summary i. recommendations a ... c. summary of drug...

  • Home
  • Documents
  • 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
18
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 208686Orig1s000 CHEMISTRY REVIEW(S)

Upload: haquynh

Post on 11-Mar-2018

221 views

Category:

Documents


8 download

Report

TRANSCRIPT

Page 1: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development

CENTER FOR DRUG EVALUATION AND RESEARCH

APPLICATION NUMBER:

208686Orig1s000

CHEMISTRY REVIEW(S)

Page 2: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 3: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 4: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 5: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 6: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 7: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 8: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 9: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 10: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 11: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 12: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 13: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 14: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 15: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 16: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 17: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 18: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development

203137Orig1s000 - Food and Drug Administration...Summary and Critical Issues: A. Summary Background Summary The application is submitted as a 505(b) (1) new drug application (NDA)

Prescription Opioids (Canadian Drug Summary) Library/CCSA-Canadian-Drug-Summary... · higher for young adults aged 20–24 at 12.8%.7 Adults (age 25+): ... Canadian Drug Summary:

H.R. 3 - Drug Price Negotiation Bill Summary 3 Drug Pricing Proposal... · H.R. 3 Title Summary TITLE I - Drug Price Negotiation Drug Selection Process k • ff 'th the Every year

Global report on antimalarial druG efficacy and druG ... · 3 Global report on antimalarial drug efficacy and drug resistance: 2000–2010 Executive summary BACkground Plasmodium

200063Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 200063orig1s000 summary review

125399Orig1s000 - Food and Drug Administration€¦ · center for drug evaluation and research application number: 125399orig1s000 summary review

Comparison/Summary Report FFY 2012 Medicaid Drug Utilization Review Annual … · 2015. 7. 1.  · Comparison/Summary Report FFY 2012 Medicaid Drug Utilization Review Annual Report

202806Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 202806orig1s000 summary review

CENTER FOR DRUG EVALUATION AND … for drug evaluation and research . application number: 125553orig1s000. summary review

Drug Treatment Court Feasibility Study · Drug Treatment Court Feasibility Study (May 2017) 1 Executive Summary Drug Treatment Courts are intended for offenders with serious drug

Mechanisms of drug hypersensitivity KDIGOkdigo.org/.../02/12.-Bircher_Mechanisms-of-Drug-Hypersensitivity-.pdf · Mechanisms of drug hypersensitivity ... Summary iron hypersensitivity

La arquitectura residencial de Joaquín Rieta Síster. El

KINDReD Final Report: Publishable summary Executive summary · KINDReD Final Report: Publishable summary Executive summary The Kinetoplastid Drug Development (KINDReD) consortium

Clandestine Drug Laboratories in South Australia: Summary

Joaquín rieta

2016 Prescription Drug Abuse Summit Summary At …gov.nv.gov/uploadedFiles/govnvgov/Content/News_and_Media/...2016 Prescription Drug Abuse Summit Summary At A Glance Governor’s Prescription

Prescription Drug Summary of Benefits

Hemophilia Factor VIII Medical Drug Program Summary

Alcohol (Canadian Drug Summary) - Canadian Centre on ... Library/CCSA-Canadian-Drug-Summary-Alcohol... · Canadian Drug Summary: Alcohol Canadian Centre on Substance Use and Addiction

Ontario Drug Benefit Formulary/Comparative Drug Index · 2020. 3. 24. · 1 . Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 . Summary of Changes – March 2020

Ontario Drug Benefit Formulary/Comparative Drug Index · 1 . Ontario Drug Benefit . Formulary/Comparative Drug Index . Edition 43 . Summary of Changes – January 2020 . Effective

WHAT Outline WHY 1. What are Adverse Drug Reactions (ADRs ...€¦ · What are Adverse Drug Reactions (ADRs)? 2. ... Drug Allergy –case summary ... Pictures-from HSA, Adverse Drug

EXECUTIVE SUMMARY OVERVIEW OF THE REGIONAL DRUG …pdea.gov.ph/images/REGIONALOFFICES/RONCR/RONCR... · EXECUTIVE SUMMARY OVERVIEW OF THE REGIONAL DRUG SITUATION Drug of Choice Barangay

Alcohol (Canadian Drug Summary) - ccsa.ca

Summary of Drug Limitations

204042Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 204042orig1s000 summary review

Healthy Montgomery Core Measures Data Summary Healthy ... › healthy...9 Healthy Montgomery Core Measures Data Summary DRUG-INDUCED MORTALITY Drug-Induced Mortality Age-Adjusted Rates,

National Drug Threat Assessment Summary 2013

Drug Policy Modelling Project · 2012-02-28 · DRUG POLICY MODELLING PROGRAM . MONOGRAPH 16. A SUMMARY OF DIVERSION PROGRAMS . FOR DRUG AND DRUG-RELATED OFFENDERS IN AUSTRALIA

Boksmart 2010-Recreational Drug Summary - SA Rugby 2010-Recreational Drug... · Recreational Drug Summary Chart 4 DRUG APPEARANCE & PRESENTATION ... / soap / grievous bodily harm

NCCP Regimen Information Summary - by Drug Last updated

Bill Title Sponsor Summary · 2019. 4. 9. · Bill Title Sponsor Summary HB 19 Prescription Drug Importation Programs Leek Prescription Drug Importation Programs: Creates programs

203109Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 203109orig1s000 summary review

Summary Report on EU Drug Precursors Seizures 2006

Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey€¦ · Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey California Environmental Protection